Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare Arm A versus Arm B in terms of PFS measured from the time of randomization after completing 6 cycles of first-line therapy for metastatic CRC: • Arm A: 5-FU/LV plus bevacizumab in combination with enzastaurin • Arm B: 5-FU/LV plus bevacizumab in combination with placebo.
Critère d'inclusion
- Locally-advanced or Metastatic Colorectal Cancer